Market Research Logo

Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Medical Devices Pipeline Assessment, 2018

Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Medical Devices Pipeline Assessment, 2018 provides an overview of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


  • Introduction
    • Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Overview
  • Products under Development
    • Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
      • Table Figure 1: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of under Development
      • Table Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of under Development
    • Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory
      • Table Figure 2: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory
      • Table Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory
    • Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path
      • Table Figure 3: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path
      • Table Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path
    • Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date
      • Table Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date
    • Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials
      • Table Figure 5: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials
      • Table Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials
  • Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products under Development by Companies
    • Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies - Pipeline Products by Stage of Development
      • Table Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies – Pipeline Products by Stage of Development
    • Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
      • Table Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of under Development
  • Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies and Product Overview
    • Boston Scientific Corp Company Overview
      • Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Acuity X4 Quad LV Lead - 1.5T MRI - Product Status
        • Table Acuity X4 Quad LV Lead - 1.5T MRI - Product Description
        • Table Acuity X4 Quad LV Lead - 3T MRI - Product Status
        • Table Acuity X4 Quad LV Lead - 3T MRI - Product Description
        • Table MRI-Safe Implantable Cardiac Rhythm Management Lead - Product Status
        • Table MRI-Safe Implantable Cardiac Rhythm Management Lead - Product Description
        • Table Next Generation ICD Lead - Product Status
        • Table Next Generation ICD Lead - Product Description
        • Table Reliance 4-Front Lead - Product Status
        • Table Reliance 4-Front Lead - Product Description
        • Table X4 SYSTEM + QUAD LEAD - Product Status
        • Table X4 SYSTEM + QUAD LEAD - Product Description
        • Table Boston Scientific Corp - Ongoing Clinical Trials Overview
        • Table Reliance 4-Front Lead - Evaluation of Acuity X4 Quadripolar Coronary Venous Leads and Reliance 4-Front Defibrillation Leads: NAVIGATE X4
        • Table Reliance 4-Front Lead - Expanding MRI Access for Patients with New and Existing ICDs and CRTDs: ENABLE MRI
    • Imricor Medical Systems Inc Company Overview
      • Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Magnetic Resonance Imaging (MRI) Compatible Lead - Product Status
        • Table Magnetic Resonance Imaging (MRI) Compatible Lead - Product Description
    • LivaNova PLC Company Overview
      • LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Beflex Brady Lead - Product Status
        • Table Beflex Brady Lead - Product Description
        • Table Nano Lead System - Product Status
        • Table Nano Lead System - Product Description
        • Table SonR Tist Lead Positioning - Product Status
        • Table SonR Tist Lead Positioning - Product Description
        • Table SonRFix Lead - Product Status
        • Table SonRFix Lead - Product Description
        • Table Tachy Lead - Product Status
        • Table Tachy Lead - Product Description
        • Table TX Brady Lead - Product Status
        • Table TX Brady Lead - Product Description
    • Mayo Clinic Company Overview
      • Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pacemaker/ICD Lead - Product Status
        • Table Pacemaker/ICD Lead - Product Description
    • Medtronic plc Company Overview
      • Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Attain Stability Quad MRI SureScan - Product Status
        • Table Attain Stability Quad MRI SureScan - Product Description
        • Table Medtronic plc - Ongoing Clinical Trials Overview
        • Table Attain Stability Quad MRI SureScan - Attain Stability Quad Clinical Study
    • MicroPort Scientific Corp Company Overview
      • MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table BonaFire - Active Pacing Lead - Product Status
        • Table BonaFire - Active Pacing Lead - Product Description
        • Table BonaFire - Passive Pacing Lead - Product Status
        • Table BonaFire - Passive Pacing Lead - Product Description
    • St. Jude Medical LLC Company Overview
      • St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Quartet NXT - Double Blend Lead - Product Status
        • Table Quartet NXT - Double Blend Lead - Product Description
        • Table Quartet NXT - Large S-Curve Lead - Product Status
        • Table Quartet NXT - Large S-Curve Lead - Product Description
        • Table Quartet NXT - Small S-Curve Lead - Product Status
        • Table Quartet NXT - Small S-Curve Lead - Product Description
        • Table Quartet Quadripolar LV Lead - MRI Labelling - Product Status
        • Table Quartet Quadripolar LV Lead - MRI Labelling - Product Description
    • Teleflex Inc Company Overview
      • Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pacemaker Lead - Product Status
        • Table Pacemaker Lead - Product Description
  • Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads- Recent Developments
    • May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC
    • May 15, 2018: MRI Interventions Announces First Quarter 2018 Results
    • May 08, 2018: T2 Biosystems Announces First Quarter 2018 Financial Results
    • May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
    • May 03, 2018: Integer Holdings Reports First Quarter 2018 Results
    • Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
    • Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
    • Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results
    • Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results
    • Mar 15, 2018: MRI Interventions Reports 34% Year-Over-Year Increase in Functional Neurology Revenues, 50% increase in Capital Sales
    • Mar 06, 2018: T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update
    • Mar 01, 2018: Safety and Effectiveness of BioTrace Medical's Tempo Lead Further Demonstrated in Multi-Center Analysis of More Than 200 Cardiac Procedures
    • Feb 28, 2018: LivaNova Announces Fourth Quarter and Full-Year 2017 Results
    • Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017
    • Feb 22, 2018: Integer Announces Strategy Focused on Portfolio Management and Operational Excellence; Aligns Senior Management to Execute Strategic Imperatives
    • Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors
    • Feb 07, 2018: Caisson Interventional Expanding in Maple Grove
    • Feb 06, 2018: MRI Interventions Announces Record 629 ClearPoint Cases in 2017
    • Feb 05, 2018: T2 Biosystems Names John Sprague As CFO
    • Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
    • Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
    • Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
    • Jan 08, 2018: LivaNova Announces Matthew J. Dodds as Senior Vice President, Corporate Development
    • Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer
    • Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
    • Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
    • Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
    • Nov 06, 2017: MRI Interventions Reports 26% Year-Over-Year Increase in Third Quarter Procedures
    • Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
    • Nov 02, 2017: T2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company Update
    • Nov 02, 2017: LivaNova Reports Third Quarter 2017 Results
    • Oct 26, 2017: BioTrace Medical Announces Key Events Featuring Tempo Temporary Pacing Lead at TCT 2017
    • Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
    • Oct 26, 2017: Integer Holdings Reports Third Quarter 2017 Results
    • Oct 09, 2017: MRI Interventions Announces Joseph Burnett As New President and CEO
    • Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
    • Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
    • Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY
    • Aug 22, 2017: Medtronic Reports First Quarter Financial Results
    • Aug 21, 2017: Medtronic Receives CE Mark for Attain Stability Quad MRI SureScan Active-Fixation Heart Lead
    • Aug 15, 2017: T2 Biosystems and Aridis Pharmaceuticals Join Antimicrobials Working Group
    • Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261%
    • Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results
    • Aug 03, 2017: T2 Biosystems Reports Second Quarter 2017 Financial Results; Provides Company Update
    • Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million
    • Aug 01, 2017: MRI Interventions Reports 79% Revenue Increase and Record Treatments in Second Quarter 2017
    • Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
    • Jul 27, 2017: Integer Holdings Reports Second Quarter 2017 Results
    • Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017
    • Jul 17, 2017: Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer
    • Jul 11, 2017: MRI Interventions Announces Record Second Quarter ClearPoint System Procedures, And a 79% Year-Over-Year Revenue Increase
    • Jul 07, 2017: MPSC New COO Glendy Wang on Board
    • Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
    • Jun 19, 2017: BioTrace Medical's Tempo Lead Shows Stability and Safety in Real-World Performance Consistent with Clinical Study Outcomes In TVT 2017 Presentation
    • Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors
    • Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel
    • Jun 08, 2017: BioTrace Medical Announces Key Activities at TVT 2017
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report